Barely Significant
← all excerpts

Comprehensive pan-cancer analysis reveals EPHB2 is a novel predictive biomarker for prognosis and immunotherapy response.

BMC Cancer · 2024 · PMC11351591 · PMID 39198775

Europe PMCDOI
1
hedged sentence
0.0010
closest p · 0.0× alpha
0.0010
boldest claim

The sentences

an increasing trendP < 0.001actually significant
An analysis linking copy number alterations to EPHB2 expression demonstrated an increasing trend correlating with higher levels of genomic amplification ( P < 0.001, Fig. 4 E).

also in 27,205 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.